Magnetic resonance imaging in the assessment of coronary artery disease

Current Atherosclerosis Reports

Volumn 7, Issue 2, 2005, Pages 108-114

  Ray, Tarang ^b   Biederman, Robert W ^b   Doyle, Mark ^b   Mankad, Sunil ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; GADOLINIUM PENTETATE; PHOSPHORUS 31; TITANIUM; VASODILATOR AGENT;

ANGIOCARDIOGRAPHY; CARDIOLOGY; CONTRAST ENHANCEMENT; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDICAL LITERATURE; METHODOLOGY; MYOCARDIAL HIBERNATION; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL RESOLUTION; PERFUSION WEIGHTED IMAGING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; SYNDROME X;

EID: 17044416900     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-005-0032-2     Document Type: Review

References (42)

1. Martin ET, Fuisz AR, Pohost GM: Imaging cardiac structure and pump function. Cardiol Clin 1998, 16:135-160.
2. Nagel E, Lehmkuhl HB, Bocksch W, et al.: Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress echocardiography. Comparison with dobutamine stress echocardiography. Circulation 1999, 99:763-770.
3. Hundley EG, Hamilton CA, Thomas MS, et al.: Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 1999, 100:1697-1702.
4. Hundley WG, Morgan TM, Neagle CM, et al.: Magnetic resonance imaging determination of cardiac prognosis. Circulation 2002, 47:2328-2333.
5. Kuijpers D, Ho KY, van Dijkman PR, et al.: Dobutamine cardiovascular magnetic resonance for the detection of myocardial ischemia with the use of myocardial tagging. Circulation 2003, 107:1592-1597.
6. Zerhouni EA, Parish DM, Rogers WJ, et al.: Human heart: tagging with MR imaging: a method for noninvasive assessment of myocardial motion. Radiology 1988, 169:59-63.
7. Rerkpattanapipat P, Morgan TM, Neagle CM, et al.: Assessment of preoperative cardiac risk with magnetic resonance imaging. Am J Cardiol 2002, 90:416-419.
8. Al-Saadi N, Nagel E, Gross M, et al.: Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 2000, 101: 379-1383.
9. Schwitter J, Nanz D, Kneifel S, et al.: Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 2001, 103:2230-2235.
10. Doyle M, Fuisz A, Kortright E, et al.: The impact of myocardial flow reserve on the detection of coronary artery disease by perfusion imaging methods: An NHLBI WISE Study. J Cardiovasc Magn Reson 2003, 5:475-485.
11. Lee DC, Simonetti OP, Harris KR, et al.: Magnetic resonance versus radionuclide pharmacological stress perfusion imaging for flow-limiting stenosis of varying severity. Circulation 2004, 110:58-65.
12. Doyle M, Pohost GM, Kortright E, et al.: In women with symptoms of ischemic heart disease, global and regional myocardial perfusion status by magnetic resonance imaging better assigns risk: results from the National Heart, Lung, and Blood Institute-sponsored WISE study. J Am Col Cardiol 2004, 43 (Suppl A):266A.
13. Panting JR, Gatehouse PD, Yang GZ, et al.: Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging [abstract]. N Engl J Med 2002, 346:1948-1953.
14. Buchthal SD, den Hollander JA, Merz NB, et al.: Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain by normal coronary angiograms. N Engl J Med 2000, 342:829-835.
15. Kwong RY, Schussheim AE, Rekhraj S, et al.: Detecting acute coronary syndrome in emergency department with cardiac magnetic resonance imaging. Circulation 2003, 107:531-537.
16. Kloner RA, Bolli R, Marban, et al.: Medical and cellular implications of stunning, hybernation, and preconditioning. An NHLBI Workshop. Circulation 1998, 97:1848-1867.
17. Baer FM, Voth E, Schneider CA, et al.: Comparison of low-dose dobutamine gradient-echo magnetic resonance imaging and positron emission tomography with [18F]-fluorodeoxyglucose in patients with chronic coronary artery disease. Circulation 1995, 81: 006-1015.
18. Baer FM, Thiessen P, Schneider CA, et al.: Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998, 31:1040-1048.
19. Sayad DE, Willett DL, Hundley WG, et al.: Dobutamine magnetic resonance imaging with myocardial tagging quantitatively predicts improvement in regional function after revascularization. Am J Cardiol 1998, 82:1149-1151.
20. Geskin G, Kramer CM, Rogers WJ, et al.: Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging. Circulation 1998, 98:217-233.
21. Kramer CM, Malkowski MJ, Mankad S, et al.: Magnetic resonance tagging and echocardiographic response to dobutamine and functional improvement after reperfused myocardial infarction. Am Heart J 2002, 143:1046-1051.
22. Zamorano J, Delgado J, Almeria C, et al.: Reason for discrepancies in identifying myocardial viability by thallium-201 redistribution, magnetic resonance imaging, and dobutamine echocardiography. Am J Cardiol 2002, 90:455-459.
23. Kramer CM, Rogers WJ, Mankad S, et al.: Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction. J Am Coll Cardiol 2000, 36:1835-1840.
24. Rogers WJ, Kramer CM, Geskin G, et al.: Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Circulation 1999, 744-750.
25. Kim RJ, Fiens DS, Parrish TB: Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999, 100:1992-2002.
26. Wu E, Judd RM, Vargas JD, et al.: Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001, 357:21-28.
27. Kim RJ, Wu E, Rafael A, et al.: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000, 343:1445-1453.
28. Fieno DS, Kim RJ, Chen EL, et al.: Contrast-enhanced magnetic resonance imaging of myocardium at risk. Distinction between reversible an irreversible injury throught infarct healing. J Am Coll Cardiol 2000, 36:1985-1991.
29. Ramani K, Judd RM, Holly TA, et al.: Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. Circulation 1998, 2687-2694.
30. Gerber BL, Garot J, Bluemke DA, et al.: Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002, 106:1083-1089.
31. Wagner A, Mahrholdt H, Holly TA, et al.: Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003, 361: 74-379.
32. Klein C, Nekolla SG, Bengel FM, et al.: Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging. Comparison with positron emission tomography. Circulation 2002, 105:162-167.
33. Selvanayagam JB, Kardos A, Francis JM, et al.: Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 2004, 110:1535-1541.
34. Kim WY, Danias PG, Stuber M, et al.: Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001, 345:1863-1869.
35. McConnell MV, Ganz P, Selwyn AP, et al.: Identification of anomalous coronary arteries and their anatomic course by magnetic resonance coronary angiography. Circulation 1995, 92:3158-3162.
36. Post JC, van Rossum AC, Bronzwaer JG, et al.: Magnetic resonance angiography of anomalous coronary arteries: a new gold standard for delineating the proximal course? Circulation 1995, 92:3163-3171.
37. van Rossum AC, Bedaux WL, Hofman MB: Morphologic and functional evaluation of coronary artery bypass conduits. J Magn Reson Imaging 1999, 10:734-740.
38. Corti R, Fuster V, Fayad ZA, et al.: Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 2002, 106:2884-2887.
39. Shunk KA, Garot J, Atalar E, Lima JA: Transesophageal magnetic resonance imaging of the aortic arch and descending thoracic aorta in patients with aortic atherosclerosis. J Am Coll Cardiol 2001, 37:2031-2035.
40. Yaun C, Beach KW, Smith LH Jr, Hatsukami TS: Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation 1998, 98: 666-2671.
41. Kim WY, Stuber M, Bornert P, et al.: Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with non-significant coronary artery disease. Circulation 2002, 106:296-299.
42. Viles-Gonzalez JF, Poon M, Sanz J, et al.: In vivo 16-slice, multidetector-row computed tomography for the assessment of experimental atherosclerosis. Comparison with magnetic resonance imaging and histopathology. Circulation 2004, 110:1467-1472.